MindRank AI signs up to RMB1.75B MDR-001 commercialization deal

MindRank AI Ltd. entered an exclusive commercialization partnership with 3SBio units for MDR-001 across mainland China, Hong Kong and Macau, with payments up to RMB1.75B. MDR-001 is in a pivotal Phase III trial in China for adults with obesity or overweight.